The tweet was deleted by the author.
But we saved everything 🙂.
Align Technology said this can enable doctors to receive and approve a treatment plan faster.
The company said this could ultimately increase office efficiency and improve the patient experience.
ALGN is trading at $175.82, above the MA-20 ($171.04), MA-50 ($173.86), and MA-200 ($160.18), signaling positive short-, medium-, and long-term momentum structure. The Ichimoku Kijun on D1 is $168.29, which acts as immediate support; near-term support levels are $173.86 (MA-50) and $168.29 (Kijun), while resistance is found at $177.65 (MA-5 cluster with MA-10) and $183.51 (Key MA-100 on W1).
Momentum signals are mixed: MACD and RSI on D1 suggest continued upward bias while ADX remains neutral, indicating weak trend strength. Oscillators like CCI and Stoch RSI show overbought conditions, and BBP also flags a buyer-dominated environment despite its overbought reading, highlighting a risk of short-term pullback. ALGN has declined $6.26 or 3.76% from last week’s close of $182.08, now positioned in the lower part of the weekly range. Weekly volatility stands at 7.46%, and current price action shows a steady decline from the high. In today’s session, the stock fell a sharp 3.44%, accentuating this downside momentum and affirming the ongoing pressure.
For the upcoming week, the projected trading range is $172.00 to $182.00, calibrated to reflect recent volatility and the current price within realistic bands and well above the 52-week low ($122.00) but below the 52-week high ($208.31). Based on MA-50-W1, RSI-W1, ADX-W1, and MACD-W1, the probability of a price increase is moderate (around 50%), making a further decline equally likely. The baseline scenario is continued sideways movement within $172.00–$182.00; a bullish scenario would require a breakout above $182.00 resistance, targeting $185.00–$188.00, while a bearish scenario sees a drop below $172.00, exposing the stock to further downside toward $168.00 support.
Previously it was reported that Align Technology was experiencing mixed momentum, with a neutral market outlook and risks balanced on both the upside and downside. Building on this, readers should now monitor any significant shifts in investor sentiment, as they could swiftly tip the prevailing scenario in either direction.